Characterization of temporal electrical activity patterns for detection of critical isthmus regions of recurrent atypical atrial flutter.


Journal

Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272

Informations de publication

Date de publication:
May 2023
Historique:
revised: 22 02 2023
received: 19 12 2022
accepted: 27 02 2023
medline: 18 5 2023
pubmed: 28 3 2023
entrez: 27 3 2023
Statut: ppublish

Résumé

Identifying the critical isthmus region (CIR) of atrial re-entry tachycardias (AT) is challenging. The Lumipoint® (LP) software, developed for the Rhythmia® mapping system, aims to facilitate the successful ablation of ATs by identifying the CIR. The objective of this study was to evaluate the quality of LP regarding the percentage of arrhythmia-relevant CIR in patients with atypical atrial flutter (AAF). In this retrospective study, we analyzed 57 AAF forms. Electrical activity (EA) was mapped over tachycardia cycle length resulting in a two-dimensional EA pattern. The hypothesis was that EA minima suggest potential CIRs with slow-conduction-zone. A total of n = 33 patients were included, with the majority of patients being already preablated (69.7%). LP algorithm identified a mean of 2.4 EA minima and 4.4 suggested CIRs per AAF form. Overall, we observed a low probability of identifying only the relevant CIR (POR) at 12.3% but a high probability that at least one CIR is detected (PALO) at 98.2%. Detailed analysis revealed EA minima depth (≤20%) and width (>50 ms) as the best predictors of relevant CIRs. Wide minima occurred rarely (17.5%), while low minima were more frequently present (75.4%). Minima depth of EA ≤ 20% showed the best PALO/POR overall (95% and 60%, respectively). Analysis in recurrent AAF ablations (five patients) revealed that CIR in de novo AAF was already detected by LP during the index procedure. The LP algorithm provides an excellent PALO (98.2%), but poor POR (12.3%) to detect the CIR in AAF. POR improved by preselection of the lowest and widest EA minima. In addition, there might be the role of initial bystander CIRs becoming relevant for future AAFs.

Identifiants

pubmed: 36971117
doi: 10.1002/clc.24009
pmc: PMC10189070
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

574-583

Informations de copyright

© 2023 The Authors. Clinical Cardiology published by Wiley Periodicals, LLC.

Références

Sci Rep. 2017 Nov 30;7(1):16678
pubmed: 29192223
Circ Arrhythm Electrophysiol. 2008 Apr;1(1):14-22
pubmed: 19808389
Cardiovasc Diagn Ther. 2019 Oct;9(Suppl 2):S247-S263
pubmed: 31737533
Clin Cardiol. 2023 May;46(5):574-583
pubmed: 36971117
J Clin Invest. 2011 Aug;121(8):2955-68
pubmed: 21804195
J Am Coll Cardiol. 2004 Sep 1;44(5):1071-9
pubmed: 15337221
Heart Rhythm. 2007 Jun;4(6):803-9
pubmed: 17556210
Circ Arrhythm Electrophysiol. 2010 Apr;3(2):160-9
pubmed: 20133933
Europace. 2019 Aug 1;21(Supplement_3):iii25-iii26
pubmed: 31400215
J Cardiovasc Electrophysiol. 2019 Dec;30(12):2797-2805
pubmed: 31646694
Heart Rhythm. 2005 May;2(5):464-71
pubmed: 15840468
Circulation. 2004 Nov 9;110(19):2996-3002
pubmed: 15520313
J Cardiovasc Electrophysiol. 2005 Nov;16(11):1138-47
pubmed: 16302893
J Cardiovasc Electrophysiol. 2009 May;20(5):480-91
pubmed: 19207747
Europace. 2019 Aug 1;21(Supplement_3):iii7-iii10
pubmed: 31400216
Curr Cardiol Rev. 2015;11(2):149-56
pubmed: 25308808
J Cardiovasc Electrophysiol. 2016 Oct;27(10):1139-1150
pubmed: 27325527
JACC Clin Electrophysiol. 2019 Apr;5(4):470-479
pubmed: 31000101
Circ Arrhythm Electrophysiol. 2018 Jun;11(6):e006019
pubmed: 29769223
Circ Arrhythm Electrophysiol. 2017 Jan;10(1):
pubmed: 28039280
Heart Rhythm. 2018 Mar;15(3):326-333
pubmed: 29081399
Circ Arrhythm Electrophysiol. 2008 Dec;1(5):344-53
pubmed: 19808429
Heart Rhythm. 2019 Nov;16(11):1652-1660
pubmed: 31004777
J Cardiovasc Electrophysiol. 2011 May;22(5):613-7
pubmed: 21235664
Circulation. 2005 Dec 13;112(24):3688-96
pubmed: 16344401

Auteurs

Nadine Vonderlin (N)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany.
German Centre for Cardiovascular Research (DZHK), Berlin, Germany.

Johannes Siebermair (J)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany.
German Centre for Cardiovascular Research (DZHK), Berlin, Germany.

Amir Mahabadi (A)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany.

Elena Pesch (E)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany.

Miriam Koehler (M)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany.

Dobromir Dobrev (D)

Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA.
Department of Medicine and Research Center, Montreal Heart Institute, Université de Montréal, Montréal, Quebec, Canada.

Rolf Alexander Janosi (RA)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany.

Tienush Rassaf (T)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany.

Reza Wakili (R)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Essen Medical School, University Duisburg-Essen, Essen, Germany.
German Centre for Cardiovascular Research (DZHK), Berlin, Germany.
Department of Cardiology and Vascular Medicine, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH